| Ytd | -98.69% | |
| 1y | -99.52% |
| Open | 0.35 | Prev Close | 0.36 | Low | 0.34 | High | 0.39 | Mkt Cap | 7.04M |
| Vol | 418.65K | Avg Vol | 1.46M | EPS | -10.71 | P/E | N/A | Forward P/E | -0.90 |
| Beta | -2.40 | Short Ratio | 1.91 | Inst. Own | 48.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 0.66 | 200-d Avg | 9.70 | 1yr Est | 15.00 |
Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-mark
Gainers Monte Rosa Therapeutics (NASDAQ:GLUE) stock rose 9.7% to $13.09 during Wednesday's afte
FingerMotion jumped 18.1% premarket after agreeing to buy Newbit Technology for $2.3M cash; NewGenIv
KALA Bio shares surge after hours after signing an LOI to acquire a nationwide telehealth platform.
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-mar
KALA Bio, Inc. (NASDAQ:KALA) ("KALA" or the "Company") today announced that on Septe
Gainers Prime Medicine (NASDAQ:PRME) shares increased by 13.0% to $3.47 during Thursday's after